Mindblown: a blog about philosophy.
-
John J De Goey Challenges Investors to Rethink Financial Optimism in Bullshift How Optimism Bias Threatens Your Finances
ONTARIO, CANADA – November 13, 2026 – Personal finance expert John J. De Goey, CIM, CFP, FP Canada FELLOW, invites investors to take a closer look at the hidden risks behind excessive optimism in his latest book, Bullshift – How Optimism Bias Threatens Your Finances. Through a thoughtful examination of behavioural biases, De Goey reveals how overly…
-
The Cook And The Backyard Buzzards Explores Decades of Urban Conversations Conflict and the Power of Forgiveness
PHOENIX, ILLINOIS – November 13, 2026 – Author LatonJa Yvette Atkins, also known as LA BOOKS, invites readers into the lively and complicated world of The Cook And The Backyard Buzzards, a raw and thought-provoking urban drama centered around decades of Sunday barbecue gatherings. Set in the Cook’s backyard over the course of more than thirty years,…
-
Primary Sclerosing Cholangitis Drugs in Development 2026: Pipeline Therapies, Ongoing Trials, and Companies Driving Innovation | Engitix, GRI Bio, Qing Bile Therapeutics, Sirnaomics, Cascade Pharma
(Albany, New York) – November 13, 2026: As per DelveInsight’s assessment, globally, Primary Sclerosing Cholangitis pipeline constitutes 14+ key companies continuously working towards developing 14+ Primary Sclerosing Cholangitis treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Primary Sclerosing Cholangitis Pipeline Insight, 2026“ report by DelveInsight…
-
Osteoporosis Market on the Rise: Growth Opportunities, Challenges, and Future Outlook Through 2036 | Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine
The Key Osteoporosis Companies in the market include – Amgen and UCB, EnteraBio, Rani Therapeutics, Lactocore, Rani Therapeutics, Jiangsu HengRui Medicine, Levolta Pharmaceuticals, Inc., Celltrion, Teva Pharmaceuticals, and others. (Albany, New York) – November 13, 2026: DelveInsight’s “Osteoporosis Market Insights, Epidemiology, and Market Forecast-2036″ report offers an in-depth understanding of the Osteoporosis, historical and…
-
Taxi Market Size to Reach USD 366.91 Billion by 2031, Driven by Urban Mobility Demand and Digital Ride-Hailing Services – Mordor Intelligence
Taxi Market Mordor Intelligence has published a new report on the Taxi Market offering a comprehensive analysis of trends, growth drivers, and future projections. Hyderabad, India, November 12, 2026 – According to Mordor Intelligence, the taxi market size is expected to grow from USD 254.36 billion in 2026 to USD 366.91 billion by 2031, registering a…
-
Rice Flour Market Size Set to Reach $2.12 Billion by 2031 Driven by Ultra-Fine Milling and Commercial Bakery Adoption – Mordor Intelligence
Rice Flour Market Size & Trends | Mordor Intelligence Mordor Intelligence has published a new report on the rice flour market, offering a comprehensive analysis of market trends, growth drivers, competitive positioning, and future opportunities. Hyderabad, November 12, 2026: According to Mordor Intelligence, the rice flour market size was valued at $1.49 billion in 2026…
-
Hypertrophic Cardiomyopathy Pipeline Insights 2026: Novel Mechanisms, Promising Candidates, and Competitive Landscape | Tenaya Therapeutics, Shandong Suncadia Medicine, MyoKardia, Imbria Pharma
(Albany, New York) – November 12, 2026: As per DelveInsight’s assessment, globally, Hypertrophic Cardiomyopathy pipeline constitutes 10+ key companies continuously working towards developing 10+ Hypertrophic Cardiomyopathy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Hypertrophic Cardiomyopathy Pipeline Insight, 2026“ report by DelveInsight outlines comprehensive insights…
-
Neuroendocrine Tumors Clinical Trials Update 2026: Phase-Wise Pipeline Status, Drug Profiles, and Key Developers | Camurus, Orano Med, Vyriad, Pfizer, Takeda Oncology, Hutchison MediPharma, Provectus
(Albany, New York) – November 12, 2026: As per DelveInsight’s assessment, globally, Neuroendocrine Tumors pipeline constitutes 115+ key companies continuously working towards developing 130+ Neuroendocrine Tumors treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Neuroendocrine Tumors Pipeline report embraces in-depth commercial and clinical assessment…
-
FG Communities Holdings Announces Third Quarter 2026 Financial Results and Provides Update on Execution of Real Estate Strategy
Company Invests $10 Million in FG Communities, Inc., Completes First Two Direct Manufactured Housing Acquisitions and Ends Third Quarter with $35.1 Million in Cash CHARLOTTE, N.C. – November 12, 2026 – FG Communities Holdings Inc. (Nasdaq: FGC, FGCPP) (formerly FG Nexus Inc.) (the “Company”), a company focused on acquiring and operating income-producing real estate, with…
-
Dreams as Divine Messages Marty Tilley Shares Her Prophetic Journey in Grasping for Spiritual Sight with Kate Delaney on Global Book Network
The Tennessee author reveals how a series of vivid, unsettling dreams opened her eyes to the ways God still speaks ADAMS, TN – November 12, 2026 – Tennessee author and woman of faith Marty Tilley recently sat down with host Kate Delaney on Global Book Network (GBN) for a featured interview about her debut release, Grasping for…
Got any book recommendations?